Cargando…
Coenzyme Q(10) prevents hepatic fibrosis, inflammation, and oxidative stress in a male rat model of poor maternal nutrition and accelerated postnatal growth(1)
Background: It is well established that low birth weight and accelerated postnatal growth increase the risk of liver dysfunction in later life. However, molecular mechanisms underlying such developmental programming are not well characterized, and potential intervention strategies are poorly defined...
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Society for Nutrition
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4733260/ https://www.ncbi.nlm.nih.gov/pubmed/26718412 http://dx.doi.org/10.3945/ajcn.115.119834 |
_version_ | 1782412806684934144 |
---|---|
author | Tarry-Adkins, Jane L Fernandez-Twinn, Denise S Hargreaves, Iain P Neergheen, Viruna Aiken, Catherine E Martin-Gronert, Malgorzata S McConnell, Josie M Ozanne, Susan E |
author_facet | Tarry-Adkins, Jane L Fernandez-Twinn, Denise S Hargreaves, Iain P Neergheen, Viruna Aiken, Catherine E Martin-Gronert, Malgorzata S McConnell, Josie M Ozanne, Susan E |
author_sort | Tarry-Adkins, Jane L |
collection | PubMed |
description | Background: It is well established that low birth weight and accelerated postnatal growth increase the risk of liver dysfunction in later life. However, molecular mechanisms underlying such developmental programming are not well characterized, and potential intervention strategies are poorly defined. Objectives: We tested the hypotheses that poor maternal nutrition and accelerated postnatal growth would lead to increased hepatic fibrosis (a pathological marker of liver dysfunction) and that postnatal supplementation with the antioxidant coenzyme Q(10) (CoQ(10)) would prevent this programmed phenotype. Design: A rat model of maternal protein restriction was used to generate low-birth-weight offspring that underwent accelerated postnatal growth (termed “recuperated”). These were compared with control rats. Offspring were weaned onto standard feed pellets with or without dietary CoQ(10) (1 mg/kg body weight per day) supplementation. At 12 mo, hepatic fibrosis, indexes of inflammation, oxidative stress, and insulin signaling were measured by histology, Western blot, ELISA, and reverse transcriptase–polymerase chain reaction. Results: Hepatic collagen deposition (diameter of deposit) was greater in recuperated offspring (mean ± SEM: 12 ± 2 μm) than in controls (5 ± 0.5 μm) (P < 0.001). This was associated with greater inflammation (interleukin 6: 38% ± 24% increase; P < 0.05; tumor necrosis factor α: 64% ± 24% increase; P < 0.05), lipid peroxidation (4-hydroxynonenal, measured by ELISA: 0.30 ± 0.02 compared with 0.19 ± 0.05 μg/mL per μg protein; P < 0.05), and hyperinsulinemia (P < 0.05). CoQ(10) supplementation increased (P < 0.01) hepatic CoQ(10) concentrations and ameliorated liver fibrosis (P < 0.001), inflammation (P < 0.001), some measures of oxidative stress (P < 0.001), and hyperinsulinemia (P < 0.01). Conclusions: Suboptimal in utero nutrition combined with accelerated postnatal catch-up growth caused more hepatic fibrosis in adulthood, which was associated with higher indexes of oxidative stress and inflammation and hyperinsulinemia. CoQ(10) supplementation prevented liver fibrosis accompanied by downregulation of oxidative stress, inflammation, and hyperinsulinemia. |
format | Online Article Text |
id | pubmed-4733260 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2016 |
publisher | American Society for Nutrition |
record_format | MEDLINE/PubMed |
spelling | pubmed-47332602016-02-09 Coenzyme Q(10) prevents hepatic fibrosis, inflammation, and oxidative stress in a male rat model of poor maternal nutrition and accelerated postnatal growth(1) Tarry-Adkins, Jane L Fernandez-Twinn, Denise S Hargreaves, Iain P Neergheen, Viruna Aiken, Catherine E Martin-Gronert, Malgorzata S McConnell, Josie M Ozanne, Susan E Am J Clin Nutr Dietary Supplements Background: It is well established that low birth weight and accelerated postnatal growth increase the risk of liver dysfunction in later life. However, molecular mechanisms underlying such developmental programming are not well characterized, and potential intervention strategies are poorly defined. Objectives: We tested the hypotheses that poor maternal nutrition and accelerated postnatal growth would lead to increased hepatic fibrosis (a pathological marker of liver dysfunction) and that postnatal supplementation with the antioxidant coenzyme Q(10) (CoQ(10)) would prevent this programmed phenotype. Design: A rat model of maternal protein restriction was used to generate low-birth-weight offspring that underwent accelerated postnatal growth (termed “recuperated”). These were compared with control rats. Offspring were weaned onto standard feed pellets with or without dietary CoQ(10) (1 mg/kg body weight per day) supplementation. At 12 mo, hepatic fibrosis, indexes of inflammation, oxidative stress, and insulin signaling were measured by histology, Western blot, ELISA, and reverse transcriptase–polymerase chain reaction. Results: Hepatic collagen deposition (diameter of deposit) was greater in recuperated offspring (mean ± SEM: 12 ± 2 μm) than in controls (5 ± 0.5 μm) (P < 0.001). This was associated with greater inflammation (interleukin 6: 38% ± 24% increase; P < 0.05; tumor necrosis factor α: 64% ± 24% increase; P < 0.05), lipid peroxidation (4-hydroxynonenal, measured by ELISA: 0.30 ± 0.02 compared with 0.19 ± 0.05 μg/mL per μg protein; P < 0.05), and hyperinsulinemia (P < 0.05). CoQ(10) supplementation increased (P < 0.01) hepatic CoQ(10) concentrations and ameliorated liver fibrosis (P < 0.001), inflammation (P < 0.001), some measures of oxidative stress (P < 0.001), and hyperinsulinemia (P < 0.01). Conclusions: Suboptimal in utero nutrition combined with accelerated postnatal catch-up growth caused more hepatic fibrosis in adulthood, which was associated with higher indexes of oxidative stress and inflammation and hyperinsulinemia. CoQ(10) supplementation prevented liver fibrosis accompanied by downregulation of oxidative stress, inflammation, and hyperinsulinemia. American Society for Nutrition 2016-02 2015-12-30 /pmc/articles/PMC4733260/ /pubmed/26718412 http://dx.doi.org/10.3945/ajcn.115.119834 Text en http://creativecommons.org/licenses/by/3.0/ This is an open access article distributed under the CC-BY license (http://creativecommons.org/licenses/by/3.0/). |
spellingShingle | Dietary Supplements Tarry-Adkins, Jane L Fernandez-Twinn, Denise S Hargreaves, Iain P Neergheen, Viruna Aiken, Catherine E Martin-Gronert, Malgorzata S McConnell, Josie M Ozanne, Susan E Coenzyme Q(10) prevents hepatic fibrosis, inflammation, and oxidative stress in a male rat model of poor maternal nutrition and accelerated postnatal growth(1) |
title | Coenzyme Q(10) prevents hepatic fibrosis, inflammation, and oxidative stress in a male rat model of poor maternal nutrition and accelerated postnatal growth(1) |
title_full | Coenzyme Q(10) prevents hepatic fibrosis, inflammation, and oxidative stress in a male rat model of poor maternal nutrition and accelerated postnatal growth(1) |
title_fullStr | Coenzyme Q(10) prevents hepatic fibrosis, inflammation, and oxidative stress in a male rat model of poor maternal nutrition and accelerated postnatal growth(1) |
title_full_unstemmed | Coenzyme Q(10) prevents hepatic fibrosis, inflammation, and oxidative stress in a male rat model of poor maternal nutrition and accelerated postnatal growth(1) |
title_short | Coenzyme Q(10) prevents hepatic fibrosis, inflammation, and oxidative stress in a male rat model of poor maternal nutrition and accelerated postnatal growth(1) |
title_sort | coenzyme q(10) prevents hepatic fibrosis, inflammation, and oxidative stress in a male rat model of poor maternal nutrition and accelerated postnatal growth(1) |
topic | Dietary Supplements |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4733260/ https://www.ncbi.nlm.nih.gov/pubmed/26718412 http://dx.doi.org/10.3945/ajcn.115.119834 |
work_keys_str_mv | AT tarryadkinsjanel coenzymeq10preventshepaticfibrosisinflammationandoxidativestressinamaleratmodelofpoormaternalnutritionandacceleratedpostnatalgrowth1 AT fernandeztwinndenises coenzymeq10preventshepaticfibrosisinflammationandoxidativestressinamaleratmodelofpoormaternalnutritionandacceleratedpostnatalgrowth1 AT hargreavesiainp coenzymeq10preventshepaticfibrosisinflammationandoxidativestressinamaleratmodelofpoormaternalnutritionandacceleratedpostnatalgrowth1 AT neergheenviruna coenzymeq10preventshepaticfibrosisinflammationandoxidativestressinamaleratmodelofpoormaternalnutritionandacceleratedpostnatalgrowth1 AT aikencatherinee coenzymeq10preventshepaticfibrosisinflammationandoxidativestressinamaleratmodelofpoormaternalnutritionandacceleratedpostnatalgrowth1 AT martingronertmalgorzatas coenzymeq10preventshepaticfibrosisinflammationandoxidativestressinamaleratmodelofpoormaternalnutritionandacceleratedpostnatalgrowth1 AT mcconnelljosiem coenzymeq10preventshepaticfibrosisinflammationandoxidativestressinamaleratmodelofpoormaternalnutritionandacceleratedpostnatalgrowth1 AT ozannesusane coenzymeq10preventshepaticfibrosisinflammationandoxidativestressinamaleratmodelofpoormaternalnutritionandacceleratedpostnatalgrowth1 |